JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touré, B. B.
Right arrow Articles by Seidah, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touré, B. B.
Right arrow Articles by Seidah, N. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 4, 2349-2358, January 28, 2000

Biosynthesis and Enzymatic Characterization of Human SKI-1/S1P and the Processing of Its Inhibitory Prosegment*

Bakary B. TouréDagger §, Jon Scott MunzerDagger , Ajoy Basakpar , Suzanne Benjannet, Jim RochemontDagger , Claude Lazure**, Michel Chrétienpar , and Nabil G. SeidahDagger Dagger Dagger

From the Laboratories of Dagger  Biochemical and  Molecular Neuroendocrinology and ** Structure and Metabolism of Neuropeptides, Protein Engineering Network of Centres of Excellence, Clinical Research Institute of Montreal, University of Montreal, Montreal, Quebec H2W 1R7 and the par  Protein Chemistry Center, Loeb Health Research Institute at the Ottawa Hospital and University of Ottawa, Ottawa, Ontario K1Y 4K9, Canada

Biochemical and enzymatic characterization of the novel human subtilase hSKI-1 was carried out in various cell lines. Within the endoplasmic reticulum of LoVo cells, proSKI-1 is converted to SKI-1 by processing of its prosegment into 26-, 24-, 14-, 10-, and 8-kDa products, some of which remain tightly associated with the enzyme. N-terminal sequencing and mass spectrometric analysis were used to map the cleavage sites of the most abundant fragments, which were confirmed by synthetic peptide processing. To characterize its in vitro enzymatic properties, we generated a secreted form of SKI-1. Our data demonstrate that SKI-1 is a Ca2+-dependent proteinase exhibiting optimal cleavage at pH 6.5. We present evidence that SKI-1 processes peptides mimicking the cleavage sites of the SKI-1 prosegment, pro-brain-derived neurotrophic factor, and the sterol regulatory element-binding protein SREBP-2. Among the candidate peptides encompassing sections of the SKI-1 prosegment, the RSLK137- and RRLL186-containing peptides were best cleaved by this enzyme. Mutagenesis of the latter peptide allowed us to develop an efficiently processed SKI-1 substrate and to assess the importance of several P and P' residues. Finally, we demonstrate that, in vitro, recombinant prosegments of SKI-1 inhibit its activity with apparent inhibitor constants of 100-200 nM.


* This work was supported in part by Medical Research Council (MRC) Group Grant MGC-11474 (to N. G. S. and M. C.), by MRC Operating Grants MT-NGS (to N. G. S.) and MT-14766 (to C. L.), and by the Government of Canada's Network of Centers of Excellence program supported by the MRC and National Sciences and Engineering Research Council of Canada through Protein Engineering Network of Centers of Excellence.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by an MRC Canada studentship.

Dagger Dagger To whom correspondence should be addressed: Clinical Research Inst. of Montreal, 110 Pine Ave. W., Montreal, Quebec H2W 1R7, Canada. Tel.: 514-987-5609; Fax: 514-987-5542; E-mail: seidahn@ircm.qc.ca.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. L. Hawkins, M. D. Robbins, L. C. Warren, D. Xia, S. F. Petras, J. J. Valentine, A. H. Varghese, I.-K. Wang, T. A. Subashi, L. D. Shelly, et al.
Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 801 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Pullikotil, S. Benjannet, J. Mayne, and N. G. Seidah
The Proprotein Convertase SKI-1/S1P: ALTERNATE TRANSLATION AND SUBCELLULAR LOCALIZATION
J. Biol. Chem., September 14, 2007; 282(37): 27402 - 27413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Pasquato, P. Pullikotil, M.-C. Asselin, M. Vacatello, L. Paolillo, F. Ghezzo, F. Basso, C. Di Bello, M. Dettin, and N. G. Seidah
The Proprotein Convertase SKI-1/S1P: IN VITRO ANALYSIS OF LASSA VIRUS GLYCOPROTEIN-DERIVED SUBSTRATES AND EX VIVO VALIDATION OF IRREVERSIBLE PEPTIDE INHIBITORS
J. Biol. Chem., August 18, 2006; 281(33): 23471 - 23481.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Stirling and P. O'Hare
CREB4, a Transmembrane bZip Transcription Factor and Potential New Substrate for Regulation and Cleavage by S1P
Mol. Biol. Cell, January 1, 2006; 17(1): 413 - 426.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Lopez de Cicco, D. E. Bassi, S. Zucker, N. G. Seidah, and A. J.P. Klein-Szanto
Human Carcinoma Cell Growth and Invasiveness Is Impaired by the Propeptide of the Ubiquitous Proprotein Convertase Furin
Cancer Res., May 15, 2005; 65(10): 4162 - 4171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Abboud-Jarrous, Z. Rangini-Guetta, H. Aingorn, R. Atzmon, S. Elgavish, T. Peretz, and I. Vlodavsky
Site-directed Mutagenesis, Proteolytic Cleavage, and Activation of Human Proheparanase
J. Biol. Chem., April 8, 2005; 280(14): 13568 - 13575.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Pullikotil, M. Vincent, S. T. Nichol, and N. G. Seidah
Development of Protein-based Inhibitors of the Proprotein of Convertase SKI-1/S1P: PROCESSING OF SREBP-2, ATF6, AND A VIRAL GLYCOPROTEIN
J. Biol. Chem., April 23, 2004; 279(17): 17338 - 17347.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. J. Vincent, A. J. Sanchez, B. R. Erickson, A. Basak, M. Chretien, N. G. Seidah, and S. T. Nichol
Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Proteolytic Processing by Subtilase SKI-1
J. Virol., August 15, 2003; 77(16): 8640 - 8649.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Okada, K. Haze, S. Nadanaka, H. Yoshida, N. G. Seidah, Y. Hirano, R. Sato, M. Negishi, and K. Mori
A Serine Protease Inhibitor Prevents Endoplasmic Reticulum Stress-induced Cleavage but Not Transport of the Membrane-bound Transcription Factor ATF6
J. Biol. Chem., August 15, 2003; 278(33): 31024 - 31032.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. R. Beyer, D. Popplau, W. Garten, D. von Laer, and O. Lenz
Endoproteolytic Processing of the Lymphocytic Choriomeningitis Virus Glycoprotein by the Subtilase SKI-1/S1P
J. Virol., March 1, 2003; 77(5): 2866 - 2872.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. G. Seidah, S. Benjannet, L. Wickham, J. Marcinkiewicz, S. B. Jasmin, S. Stifani, A. Basak, A. Prat, and M. Chretien
The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation
PNAS, February 4, 2003; 100(3): 928 - 933.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Nour, A. Basak, M. Chretien, and N. G. Seidah
Structure-Function Analysis of the Prosegment of the Proprotein Convertase PC5A
J. Biol. Chem., January 24, 2003; 278(5): 2886 - 2895.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. J. Sanchez, M. J. Vincent, and S. T. Nichol
Characterization of the Glycoproteins of Crimean-Congo Hemorrhagic Fever Virus
J. Virol., June 14, 2002; 76(14): 7263 - 7275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Elagoz, S. Benjannet, A. Mammarbassi, L. Wickham, and N. G. Seidah
Biosynthesis and Cellular Trafficking of the Convertase SKI-1/S1P. ECTODOMAIN SHEDDING REQUIRES SKI-1 ACTIVITY
J. Biol. Chem., March 22, 2002; 277(13): 11265 - 11275.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Lenz, J. ter Meulen, H.-D. Klenk, N. G. Seidah, and W. Garten
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P
PNAS, October 12, 2001; (2001) 221447598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Benjannet, A. Elagoz, L. Wickham, M. Mamarbachi, J. S. Munzer, A. Basak, C. Lazure, J. A. Cromlish, S. Sisodia, F. Checler, et al.
Post-translational Processing of beta -Secretase (beta -Amyloid-converting Enzyme) and Its Ectodomain Shedding. THE PRO- AND TRANSMEMBRANE/CYTOSOLIC DOMAINS AFFECT ITS CELLULAR ACTIVITY AND AMYLOID-beta PRODUCTION
J. Biol. Chem., March 30, 2001; 276(14): 10879 - 10887.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Lenz, J. ter Meulen, H.-D. Klenk, N. G. Seidah, and W. Garten
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P
PNAS, October 23, 2001; 98(22): 12701 - 12705.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.